(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
5 days till quarter result
(bmo 2024-05-16)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research, production, and sale of various drugs in China. The company offers Su Ling product in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery...
Stats | |
---|---|
Today's Volume | 1.17M |
Average Volume | 1.70M |
Market Cap | 4.96B |
EPS | CNY0.361 ( 2023-10-27 ) |
Next earnings date | ( CNY0 ) 2024-05-16 |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 29.64 |
ATR14 | CNY0.0470 (0.15%) |
Volume Correlation
Beijing Konruns Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Beijing Konruns Correlation - Currency/Commodity
Beijing Konruns Financials
Annual | 2023 |
Revenue: | CNY920.01M |
Gross Profit: | CNY818.96M (89.02 %) |
EPS: | CNY0.960 |
FY | 2023 |
Revenue: | CNY920.01M |
Gross Profit: | CNY818.96M (89.02 %) |
EPS: | CNY0.960 |
FY | 2022 |
Revenue: | CNY866.73M |
Gross Profit: | CNY740.57M (85.44 %) |
EPS: | CNY0.650 |
FY | 2021 |
Revenue: | CNY809.78M |
Gross Profit: | CNY704.02M (86.94 %) |
EPS: | CNY0.940 |
Financial Reports:
No articles found.
Beijing Konruns
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research, production, and sale of various drugs in China. The company offers Su Ling product in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It also engages in the development of drug candidates, including CX1026, CX1003, and KC1036. The company was founded in 2003 and is headquartered in Beijing, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators